Determinants | Low Level Physical Activity(LLPA) | COR (95% CI) | P-value | |
---|---|---|---|---|
Cases (n = 262) | Controls (n = 371) | |||
No | No | |||
ART status | ||||
ART-naive | 84 | 127 | 1 | |
ART exposed | 178 | 244 | 1.10(0.79–1.54) | 0.06*** |
Type of ART regimen | ||||
Non-in either of the two Therapy (Rx)a | 84 | 127 | 1 | |
1st line | 176 | 236 | 1.13(0.81–1.58) | 0.49 |
2nd line | 2 | 8 | 0.38(0.08–1.82) | 0.23*** |
1st line ART regimen | ||||
AZT-3TC-NVP | 36 | 43 | 1 | |
AZT-3TC-EFV | 18 | 17 | 1.27(0.57–2.81) | 0.56 |
TDF-3TC-EFV | 102 | 137 | 0.89(0.53–1.48) | 0.65 |
TDF + 3TC + NVP | 20 | 35 | 0.68(0.34–1.38) | 0.29 |
ABC + 3TC + EFV | 86 | 4 | NC | |
NA /Not applicable | 36 | 135 | 0.76(0.45–1.28) | 0.30 |
Duration since diagnosed with HIV | ||||
< 1 year | 33 | 55 | 1 | |
1–4 Years | 208 | 275 | 1.26(0.79–2.01) | 0.33 |
5–9 Years | 21 | 41 | 0.85(0.43–1.69) | 0.65 |
Duration since on ART | ||||
< 1 year | 55 | 16 | ||
1–4 Years | 48 | 113 | 0.12(0.06–0.24) | 0.000** |
5–9 Years | 43 | 95 | 0.13(0.07–0.26) | 0.000** |
Functional status | ||||
Ambulatory | 73 | 99 | ||
Working | 189 | 272 | 0.94(0.66–1.34) | 0.74 |
WHO staging | ||||
< III stage | 215 | 274 | ||
≥ III stage | 42 | 92 | 0.58(0.39–0.87) | 0.009** |
OI other than TB | ||||
No | 232 | 307 | ||
Yes | 30 | 64 | 0.62(0.39–0.99) | 0.04* |
Recent TB status | ||||
No | 223 | 318 | 1 | |
Yes | 39 | 53 | 1.05(0.67–1.64) | 0.83 |
CD4-levels cells mm3 | ||||
< 350 | 37 | 50 | 1 | |
350–500 | 64 | 84 | 1.03(0.60–1.76) | 0.92 |
≥500 | 161 | 237 | 0.92(0.57–1.47) | 0.72 |
Viral RNA levels > = 1500 copies/ml | ||||
No | 252 | 358 | 1 | |
Yes | 10 | 13 | 0.92(0.40–2.12) | 0.84 |